Nasim Farach

Mr. Nasim Farach

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2015 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
NFNasim Farach
Nasim Farach
GFGladys Faba
Gladys Faba
SMSoroya Julian Julian McFarlane
Soroya Julian Julian McFarlane
FMFelipe Mejía
Felipe Mejía
Baltica CabiesesBaltica Cabieses
Baltica Cabieses
ACAndrea A. Cortinois
Andrea A. Cortinois
A multidisciplinary journal that focuses on public health and technology, public health informatics, mass media campaigns, surveillance, and innovation in public health practice and research. Also dedicated to rapid open data sharing during epidemics.

Verified
Journal Article
Open access
PDF file
LCLissette R Chang
Lissette R Chang
CGCristine Gutierrez
Cristine Gutierrez
JRJose Rodas
Jose Rodas
NANancy Aitcheson
Nancy Aitcheson
NFNasim Farach
Nasim Farach
BPBenjamin Ryan Phelps
Benjamin Ryan Phelps
To better understand recent adolescent (10–19 years) HIV trends in Central America, we analyzed routine data from countries supported by the United States President’s Emergency Plan for AIDS Relief (PEPFAR): Guatemala, El Salvador, Honduras, Panama, and Nicaragua, over the period from October 2020 to September 2024. Key PEPFAR indicators included HIV testing, HIV positivity rates, new treatment initiations, advanced HIV disease (AHD) at diagnosis, viral load coverage (VLC), viral load suppression (VLS), and multi-month dispensing (MMD) uptake for children and adolescents living with HIV (CALHIV) from 10–19 years of age. Since October 2020, the number of HIV tests conducted among adolescents has increased; however, the positivity rate has remained stable at approximately 2%. The number of adolescents initiating treatment increased by 21%. At the same time, VLS has shown steady regional improvement (from 73% to 90%), though VLC is a persistent challenge (80%). Treatment interruption rates have been relatively stable, fluctuating between 2% and 3%. Advanced HIV is high in adolescents new to treatment (34%), especially among females (40%), though cluster of differentiation 4 (CD4) testing at diagnosis has only been collected recently and coverage is not complete. The high prevalence of AHD among adolescents underscores the need to reinforce earlier and more targeted interventions for adolescents, especially in countries with greater HIV prevalence such as Panama and Guatemala.

22 August 2024 in Evaluation and Program Planning
Verified
Journal Article
Closed access
ARAnna Russell
Anna Russell
SGSmita Ghosh
Smita Ghosh
NTNiharika Tiwari
Niharika Tiwari
CVClarissa Valdez
Clarissa Valdez
LTLeigh Tally
Leigh Tally
JAJohn Aberle-Grasse
John Aberle-Grasse